Contact

Amplity Medical →

Outsourcing global clinical

& medical engagement for accelerated drug approval

& acceptance

Amplity Sales →

Flexible, scalable sales teams for rapid product launch

& lifecycle management

Amplity Intel →

Real-time patient-level insights powered by a
one-of-a-kind comprehensive
qualitative database + platform — AnswerY™

Amplity Comms →

Premium content & audience access to critical oncology care networks

Amplity Learn →

Continuous growth for teams and individuals led by pharma industry experts

Who We Are

Leadership

Who We Are

Leadership

Amplity Medical →
Amplity Sales →
Amplity Intel →
Amplity Comms →
Amplity Learn →

Expertise

Our Work

Our News

Careers

Contact Us

Who We Are

Leadership
Amplity Medical →
Amplity Sales →
Amplity Intel →
Amplity Comms →
Amplity Learn →

Expertise

Our Work

Our News

Careers
Contact Us

Pioneering Innovation

Our News

Meet Ava, Amplity’s new AI-powered chatbot designed to deliver faster, more personalized digital experiences on .
Read Article arrow
  • Press Release
  • Press Release

Meet Ava: Amplity’s AI Chatbot Enhancing Web UX

  • May 28, 2025 • AI + NLP, Company Updates, Technology
  • Research
Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS) are rare, childhood-onset, developmental epileptic encephalopathies.
Explore Research arrow

Exploring The Clinical Burden Of Dravet Syndrome & Lennox-Gastaut Syndrome 

May 30, 2025
  • Article
There is a growing push to leverage diverse data sources to enrich RWD insights. 
Read Article arrow

Advancing RWD: 5 Takeaways From ISPOR 2025

May 29, 2025
  • Press Release
Meet Ava, Amplity’s new AI-powered chatbot designed to deliver faster, more personalized digital experiences on .
Read Article arrow

Meet Ava: Amplity’s AI Chatbot Enhancing Web UX

May 28, 2025
  • Article
Read Article arrow

Building Trust on Pharma Teams: Key to High Performance

May 22, 2025
  • Research
NLP Unlocks Patterns In Myasthenia Gravis Progression
Explore Research arrow

NLP Unlocks Patterns In Myasthenia Gravis Progression

May 21, 2025
  • Research
Myasthenia gravis (MG) is a rare, chronic, autoantibody-mediated neuromuscular disorder.
Explore Research arrow

Myasthenia Gravis Crisis: Treatment Challenges & Triggers 

May 21, 2025
  • Research
Lung cancer is a common and deadly cancer in the United States.
Explore Research arrow

Streamlining NSCLC Patient Identification

May 21, 2025
  • Research
Early TKI Disruptions In ROS1+ NSCLC Reveal Treatment Gaps
Explore Research arrow

Early TKI Disruptions In ROS1+ NSCLC Reveal Treatment Gaps 

May 21, 2025
  • Research
Gastric cancer ranks among the most prevalent cancers globally. 
Read Now arrow

Closing Care Gaps In Gastric Cancer

May 15, 2025

Events and Webinars

  • Conference

ASCO 2025

  • May 30, 2025
  • - Jun 3, 2025
  • May 30, 2025
  • - Jun 3, 2025

•

  • Conference
  • Conference

LTEN 2025 | Aurora, CO

  • Jul 28, 2025
  • - Jul 31, 2025
  • Jul 28, 2025
  • - Jul 31, 2025

•

  • Conference
Powerful Partnerships Start Here
Get in Touch
Amplity.svg
About
Who We Are
Leadership
Services
Amplity Medical
Amplity Sales
Amplity Intel
Amplity Comms
Amplity Learn
Expertise
Our Work
Our News
Articles
Events
Multimedia
Press Release
Research
Careers
Contact
Amplity, Inc.
2080 Cabot Blvd W #100
Langhorne, PA 19047
© 2025 Amplity, Inc. All Rights Reserved.
Privacy & Cookie Statements
Terms of Use